Acute myeloid leukemia and myelodysplastic syndrome after doxorubicin-cyclophosphamide adjuvant therapy for operable breast cancer: the National Surgical Adjuvant Breast and Bowel Project Experience.
about
Racial and ethnic differences in risk of second primary cancers among breast cancer survivorsThe use of biomonitoring data in exposure and human health risk assessment: benzene case studyHaematological malignancies developing in previously healthy individuals who received haematopoietic growth factors: report from the Research on Adverse Drug Events and Reports (RADAR) project.Drug-induced hematologic syndromesCongenital neutropenia: diagnosis, molecular bases and patient management.Phase III randomized trial of dose intensive neoadjuvant chemotherapy with or without G-CSF in locally advanced breast cancer: long-term resultsEvaluation of Peripheral Blood Smear for Myelodysplasia in Breast Cancer Patients who Received Adjuvant Antracycline.Oncologist use of the Adjuvant! model for risk communication: a pilot study examining patient knowledge of 10-year prognosis.Recurrent metastatic neuroblastoma followed by myelodysplastic syndrome: possible leukemogenic role of temozolomideGranulocyte colony-stimulating factor: molecular mechanisms of action during steady state and 'emergency' hematopoiesis.Reduced risk of secondary leukemia with fewer cycles of dose-intensive induction chemotherapy in patients with neuroblastomaOutcome of allo-SCT for women with MDS or AML occurring after breast cancer therapyIncreased incidence of myelodysplastic syndrome and acute myeloid leukemia following breast cancer treatment with radiation alone or combined with chemotherapy: a registry cohort analysis 1990-2005.Adjuvant chemotherapy in breast cancer: To use or not to use, the anthracyclinesAcute myeloid leukemia of donor origin after allogeneic stem cell transplantation from a sibling who harbors germline XPD and XRCC3 homozygous polymorphisms.The Role of Supportive Therapy in the Era of Modern Adjuvant Treatment - Current and Future Tools.Risk of hospitalization according to chemotherapy regimen in early-stage breast cancer.Therapy-related acute leukemia in breast cancer patients: twelve cases treated with a topoisomerase inhibitor.Screening for clonal hematopoiesis as a predictive marker for development of therapy-related myeloid neoplasia (t-MN) following neoadjuvant therapy for breast cancer: a Southwest Oncology Group study (S0012).Current knowledge and future research directions in treatment-related second primary malignancies.Risk of marrow neoplasms after adjuvant breast cancer therapy: the national comprehensive cancer network experience.Breast cancer survivorship: a comprehensive review of long-term medical issues and lifestyle recommendations.The cost-utility of adjuvant chemotherapy using docetaxel and cyclophosphamide compared with doxorubicin and cyclophosphamide in breast cancer.Early breast cancer in the older woman.Second malignancies among elderly survivors of cancer.Therapy-related myelodysplasia and acute myeloid leukemia after Ewing sarcoma and primitive neuroectodermal tumor of bone: A report from the Children's Oncology GroupIncidence of acute myeloid leukemia after breast cancer.Clinical practice guidelines for the care and treatment of breast cancer: 16. Locoregional post-mastectomy radiotherapy.A way forward on the medically appropriate use of white cell growth factorsCost-effectiveness and resource use of implementing MRI-guided NACT in ER-positive/HER2-negative breast cancers in The Netherlands.Risk of second cancer after initial treatment of breast cancer: An Osaka Cancer Registry Database study.Radiotherapy- and chemotherapy-induced myelodysplasia syndrome: a nationwide population-based nested case-control study.Ten-year follow-up of unrelated volunteer granulocyte donors who have received multiple cycles of granulocyte-colony-stimulating factor and dexamethasone.A role for microRNAs in maintenance of mouse mammary epithelial progenitor cells.Simultaneous presentation of acute monoblastic leukemia and mantle cell lymphoma: case report and review of the literature.Quantitative Gene Expression by Recurrence Score in ER-Positive Breast Cancer, by Age.Inherited mutations in cancer susceptibility genes are common among survivors of breast cancer who develop therapy-related leukemia.Myelodysplastic syndrome and acute myeloid leukemia following adjuvant chemotherapy with and without granulocyte colony-stimulating factors for breast cancer.Canadian supportive care recommendations for the management of neutropenia in patients with cancer.Does chemotherapy-induced neutropaenia result in a postponement of adjuvant or neoadjuvant regimens in breast cancer patients? Results of a retrospective analysis.
P2860
Q27317129-B45781C4-5CD6-4935-B6F7-74BD8EEE89DBQ28395056-C75FA82E-FA04-434B-AFA8-C82EB1F2CB02Q33373051-6DCC0090-464D-482C-8301-62D3DD54AB16Q33387312-39D8BDF7-796E-49CD-940A-752511BE3C83Q33395402-BBB51AE1-DFAA-48F8-A439-7CDAB167DE6CQ33397922-E0E39C7A-C864-4E1F-881E-3C8189DDBBAEQ33419927-434F270F-959A-4172-B357-212CA6E7AA02Q33436043-43B8ACC7-387E-457D-AF9F-CC925701BCEAQ33566420-F9B85CCD-5E05-4449-84FC-792477AB0A51Q33780538-5772D833-849E-4C44-89F0-AC07F73BF0D3Q33836091-5A80F69C-E56B-42AF-827E-88522C1DC1A2Q33928011-655A4D9F-CB93-4B29-BED4-655312AC86B1Q33938533-6CAD26A5-B9C0-4552-BB96-E3297B948E76Q34023749-C1FDD731-ABA5-4554-B3EE-F278F687453EQ34032840-50AC65D0-9032-44E7-A68C-A23D8F6F9BC0Q34095827-E650037B-FA97-462A-8183-7E0B503FF431Q34184798-5E0B3812-3DAF-4436-84C5-238A38DE32C7Q34316981-448EA75D-3DA7-4872-8F5A-322796B57560Q34510187-6C9C39B5-400C-4149-9419-708E2DE5B0C9Q34604460-38E41994-CE37-4766-B2DB-9CFCA4E171ABQ34996659-3AA22745-8EE2-4C7C-BDB7-CBD7BFC4DB19Q35490056-B3D1B4F8-EABA-442D-818A-3BACB153790CQ35573019-DE7A714C-224E-41C1-9C63-8D9C27081E6CQ35584539-D1729DDF-05EF-4592-B0E7-9E5B7C10FDF9Q35599802-AB6EDE76-5AA0-4BC6-98FD-2427F3F8C5D4Q35615792-47944F5E-7045-4101-99CE-ABAC9D75A3D7Q35640784-BE71BCB4-CEB5-4B96-BC9F-42C919891C5AQ35743986-4ECDB736-8C0F-489F-94B1-EAB75129876FQ36058245-67872BB0-8324-4BE4-ABFB-35FE493D1141Q36123151-1D568FD3-AE0E-42DB-8D0B-4B4718F82B3FQ36126599-82D67D1B-B839-402A-A8C0-F448225E4799Q36153838-51CD7B6F-855E-48BC-A12F-FA2B678FEDCCQ36180365-BB51D61B-A235-4B57-B1A9-2713D37E3264Q36209715-C3245CC2-797C-43AA-95D9-A0702A14F295Q36303461-4AE5B766-DD50-4650-8A7A-8B034C375D3FQ36373733-7DB5563E-8E75-40A8-BDDC-BB6259E1D0F3Q36450186-A2E4F1A8-608F-4509-841A-009ED8CDCB70Q36479390-BE55E21F-0437-4BF8-AE97-F2361A012C65Q36485208-88B736A8-0F08-46C4-8792-19C3AE80C06CQ36610747-AF759422-CAA7-4547-9E82-C56600A38721
P2860
Acute myeloid leukemia and myelodysplastic syndrome after doxorubicin-cyclophosphamide adjuvant therapy for operable breast cancer: the National Surgical Adjuvant Breast and Bowel Project Experience.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Acute myeloid leukemia and mye ...... and Bowel Project Experience.
@en
Acute myeloid leukemia and mye ...... and Bowel Project Experience.
@nl
type
label
Acute myeloid leukemia and mye ...... and Bowel Project Experience.
@en
Acute myeloid leukemia and mye ...... and Bowel Project Experience.
@nl
prefLabel
Acute myeloid leukemia and mye ...... and Bowel Project Experience.
@en
Acute myeloid leukemia and mye ...... and Bowel Project Experience.
@nl
P2093
P356
P1476
Acute myeloid leukemia and mye ...... and Bowel Project Experience.
@en
P2093
Arthur DeCillis
John Bryant
National Surgical Adjuvant Breast and Bowel Project Experience
Roy E Smith
P304
P356
10.1200/JCO.2003.03.114
P407
P577
2003-04-01T00:00:00Z